GS 9723
Alternative Names: Effector IgG2 - Gilead Sciences; GS-9723Latest Information Update: 17 Jun 2021
At a glance
- Originator Gilead Sciences
- Class Antiretrovirals; Immunoglobulins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections